0000899243-22-037468.txt : 20221202
0000899243-22-037468.hdr.sgml : 20221202
20221202173333
ACCESSION NUMBER: 0000899243-22-037468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221130
FILED AS OF DATE: 20221202
DATE AS OF CHANGE: 20221202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NSV Partners III GP LLC
CENTRAL INDEX KEY: 0001889601
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 221443142
BUSINESS ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 2126885100
MAIL ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NSV Partners III LP
CENTRAL INDEX KEY: 0001890004
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 221443143
BUSINESS ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 2126885100
MAIL ADDRESS:
STREET 1: 500 WEST PUTNAM AVE
STREET 2: SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-30
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001890004
NSV Partners III LP
500 WEST PUTNAM AVENUE, SUITE 400
GREENWICH
CT
06830
0
0
1
0
0001889601
NSV Partners III GP LLC
500 WEST PUTNAM AVENUE, SUITE 400
GREENWICH
CT
06830
0
0
1
0
Common Stock
2022-11-30
4
S
0
143228
29.0148
D
16745365
I
See Footnotes
Common Stock
2022-12-01
4
S
0
129317
29.0074
D
16616048
I
See Footnotes
Represents the weighted average share price of an aggregate total of 143,228 shares sold in the price range of $29.00 to $29.17. The reporting owners undertake to provide upon request by the Securities and Exchange Commission ("Commission") staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Consists of (i) 5,873,225 shares held by NSV Investments I, LP, (ii) 2,295,172 shares held by NSV Master Limited Partnership II, LP, (iii) 2,005,725 shares held by NSV 2019 Opportunities Fund, LP, (iv) 1,731,080 shares held by NSV 2018 New Horizons Fund, LP, (v) 1,323,264 shares held by Life & Tech, (vi) 1,179,921 shares held by NSV Investments III, LP, (vii) 998,099 shares held by NSV Investments II, LP, (viii) 434,423 shares held by New Science Ventures, LLC, (ix) 270,682 shares held by NSV Growth Opportunities Fund, LP, (x) 185,779 shares held by New Science Ventures Fund III, LP, (xi) 163,286 shares held by NSV 2017 Opportunities Fund, LP, (xii) 113,862 shares held by NSV 2018 Opportunities Fund, LP, (xiii) 88,065 shares held by NSV 2016 Opportunities Fund, LP, (xiv) 58,565 shares held by New Science Ventures Fund III (Offshore), LP, and (xv) 24,217 shares held by NSV 2016 Opportunities Fund (Offshore), LP, collectively the NSV funds.
NSV Partners III, LP, is the general partner of NSV 2018 New Horizons Fund LP, NSV Investments I, LP, NSV 2018 Opportunities Fund, LP, NSV 2019 Opportunities Fund, LP, NSV Growth Opportunities Fund, LP, NSV Investments III, LP, and NSV Investments II, LP. NSV Partners II, LLC, is the general partner of New Science Ventures Fund III, LP, New Science Ventures Fund III (Offshore), LP, NSV 2016 Opportunities Fund, LP, NSV 2016 Opportunities Fund (Offshore), LP, NSV 2017 Opportunities Fund, LP, and NSV Master Limited Partnership II, LP.
Somasundaram Subramaniam is the majority member and managing member of NSV Partners III GP, LLC, and may be deemed to have voting and dispositive power over the shares held by each entity of which NSV Partners III, LP is general partner. Mr. Subramaniam disclaims beneficial ownership over the shares held by each of the NSV funds, except to the extent of his pecuniary interest therein. Mr. Subramaniam is the majority member and managing member NSV Partners II, LLC, and may be deemed to have voting and dispositive power over the shares held by each entity of which NSV Partners II, LLC is general partner. Mr. Subramaniam is a director of the issuer and files separate Section 16 reports.
Represents the weighted average share price of an aggregate total of 129,317 shares sold in the price range of $29.00 to $29.54. The reporting owners undertake to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Consists of (i) 5,873,225 shares held by NSV Investments I, LP, (ii) 2,295,172 shares held by NSV Master Limited Partnership II, LP, (iii) 1,990,010 shares held by NSV 2019 Opportunities Fund, LP, (iv) 1,704,590 shares held by NSV 2018 New Horizons Fund, LP, (v) 1,323,264 shares held by Life & Tech, (vi) 1,179,921 shares held by NSV Investments III, LP, (vii) 998,099 shares held by NSV Investments II, LP, (viii) 434,423 shares held by New Science Ventures, LLC, (ix) 269,055 shares held by NSV Growth Opportunities Fund, LP, (x) 160,722 shares held by New Science Ventures Fund III, LP, (xi) 141,262 shares held by NSV 2017 Opportunities Fund, LP, (xii) 98,504 shares held by NSV 2018 Opportunities Fund, LP, (xiii) 76,186 shares held by NSV 2016 Opportunities Fund, LP, (xiv) 50,665 shares held by New Science Ventures Fund III (Offshore), LP, and (xv) 20,950 shares held by NSV 2016 Opportunities Fund (Offshore), LP.
/s/ NSV Partners III, LP, By: Tom Lavin, Partner
2022-12-02
/s/ NSV Partners III GP, LLC, By: Tom Lavin, Partner
2022-12-02